2022
DOI: 10.1021/acsanm.1c03399
|View full text |Cite
|
Sign up to set email alerts
|

Peptide-Integrated Superparamagnetic Nanoparticles for the Identification of Epitopes from SARS-CoV-2 Spike and Nucleocapsid Proteins

Abstract: The COVID-19 pandemic, caused by the fast transmission and spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently considered a serious health problem, requiring an effective strategy to contain SARS-CoV-2 dissemination. For this purpose, epitopes of the SARS-CoV-2 spike (S) and sucleocapsid (N) proteins were identified by bioinformatics tools, and peptides that mimic these epitopes were chemically synthesized and then conjugated to superparamagnetic nanoparticles (SPMNPs). Three p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 59 publications
(174 reference statements)
0
3
0
Order By: Relevance
“…Bioinformatic tools to predict antigenic epitopes that are specific for the pathogens have been advancing the development of new diagnostics. Many epitopes have been identified by immunoinformatics prediction or immunoassays and the peptides validated by serological assays, such as ELISA [ 22 , 23 , 24 , 25 ]. Epitope-based chimeric proteins have been then proposed as recombinant proteins for the development of new COVID-19 vaccines or diagnostics, showing stronger immunogenicity with the possibility to express proteins in a simpler prokaryotic system [ 13 , 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Bioinformatic tools to predict antigenic epitopes that are specific for the pathogens have been advancing the development of new diagnostics. Many epitopes have been identified by immunoinformatics prediction or immunoassays and the peptides validated by serological assays, such as ELISA [ 22 , 23 , 24 , 25 ]. Epitope-based chimeric proteins have been then proposed as recombinant proteins for the development of new COVID-19 vaccines or diagnostics, showing stronger immunogenicity with the possibility to express proteins in a simpler prokaryotic system [ 13 , 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, fluorescence detection based on fluorescent materials is constrained by significant background noise and fluorescence quenching, whereas colloidal gold exhibits low sensitivity and a narrow dynamic range . Magnetic particles (MNPs) exhibit superior biocompatibility, stability, and ease of collection under external magnetic fields and are frequently employed in the enrichment of proteins, , nucleic acids, , rare cells, and ICTs. , The MNP-based immunochromatographic test (MICT) has been successfully employed in the quantitative detection of viruses, bacteria, and cancer biomarkers because of the high signal to noise ratio and wide linear dynamic detection range of MNPs. However, a lot of core-shell MNPs from commercial often agglomerate during an immunochromatographic test.…”
Section: Introductionmentioning
confidence: 99%
“…Compared to traditional ELISA, the B-cell epitope-based QD biosensor exhibited higher sensitivity (92.3–98.1% positive rates in 207 COVID-19 patient sera) while requiring less time (5 min) and labor. Scussel et al conducted a nanomagnetic peptide-based ELISA that employed superparamagnetic nanoparticles (SPMNPs) conjugated with peptides/epitopes of the S and N proteins for detecting COVID-19 [ 15 ]. Among the peptides tested, the p2pS mimotope exhibited optimal performance, achieving excellent sensitivity and specificity.…”
mentioning
confidence: 99%